Table 3. Distribution of the type of hospital stay for patients accounted for the economic analysis, i.e. with a first hospital admission for potentially HPV-related cancer of interest in 2011, to the exclusion of patients with another primary tumour.
Female genital cancer | Anal cancer | Head and Neck cancers (HNCs) | ||||
---|---|---|---|---|---|---|
Cervical cancer | Vulvar cancer | Vaginal cancer | - | Oral cavity cancer | Oropharyngeal cancer | |
Surgery | 1 630 (54.2%) | 332 (70.5%) | 82 (29.4%) | 455 (30.8%) | 1 967 (62.7%) | 1 937 (32.2%) |
Chemotherapy | 1 769 (58.9%) | 127 (27.0%) | 123 (44.1%) | 956 (64.8%) | 1 371 (43.7%) | 3 933 (65.4%) |
Inpatient radiotherapy | 1 742 (58.0%) | 158 (33.5%) | 176 (63.1%) | 772 (52.3%) | 1 267 (40.4%) | 2 673 (44.4%) |
Palliative care | 745 (24.8%) | 151 (32.1%) | 77 (27.6%) | 263 (17.8%) | 804 (25.6%) | 1 546 (25.7%) |